NOVONESIS (NOVOZYMES) B (NZM2.DE) Stock Price, Forecast & Analysis
Europe - Frankfurt Stock Exchange - FRA:NZM2 - DK0060336014 - Common Stock
NZM2.DE Key Statistics, Chart & Performance
The current stock price of NZM2.DE is 56.02 EUR. In the past month the price increased by 4.91%.
NZM2.DE Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to NZM2.DE.
NZM2.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to NZM2.DE. NZM2.DE has an average financial health and profitability rating.
NZM2.DE Financial Highlights
Over the last trailing twelve months NZM2.DE reported a non-GAAP Earnings per Share(EPS) of 1.51. The EPS decreased by -54.35% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 13.61% | ||
| ROA | 4.31% | ||
| ROE | 6.54% | ||
| Debt/Equity | 0.26 |
NZM2.DE Forecast & Estimates
22 analysts have analysed NZM2.DE and the average price target is 64.71 EUR. This implies a price increase of 15.51% is expected in the next year compared to the current price of 56.02.
For the next year, analysts expect an EPS growth of 44.83% and a revenue growth 6.01% for NZM2.DE
NZM2.DE Ownership
NZM2.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| SY1.DE | SYMRISE AG | 20.57 | 10.44B | ||
| AKZA.AS | AKZO NOBEL N.V. | 16.36 | 10.19B | ||
| AKU1.DE | AKZO NOBEL N.V. | 16.2 | 10.09B | ||
| SYENS.BR | SYENSQO SA | 22.17 | 7.49B | ||
| EVK.DE | EVONIK INDUSTRIES AG | 9.83 | 6.23B | ||
| NVJP.DE | UMICORE | 17.37 | 4.84B | ||
| UMI.BR | UMICORE | 17.15 | 4.78B | ||
| AKE.PA | ARKEMA | 10.1 | 3.96B | ||
| WCH.DE | WACKER CHEMIE AG | 169.65 | 3.80B | ||
| RBT.PA | ROBERTET SA | 19.19 | 1.95B | ||
| ACT.DE | ALZCHEM GROUP AG | 26.69 | 1.66B | ||
| CRBN.AS | CORBION NV | 17.44 | 1.14B |
Related stock screener links
About NZM2.DE
Company Profile
Novonesis (Novozymes A/S) engages in the era of biosolutions. The firm operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. The company develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Bayer and Syngenta in Agriculture and DSM and Adisseo in Animal Health & Nutrition..
Company Info
NOVONESIS (NOVOZYMES) B
Krogshoejvej 36
Bagsvaerd DK
Employees: 10582
NOVONESIS (NOVOZYMES) B / NZM2.DE FAQ
What does NOVONESIS (NOVOZYMES) B do?
Novonesis (Novozymes A/S) engages in the era of biosolutions. The firm operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. The company develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Bayer and Syngenta in Agriculture and DSM and Adisseo in Animal Health & Nutrition..
What is the current price of NZM2 stock?
The current stock price of NZM2.DE is 56.02 EUR. The price increased by 0.94% in the last trading session.
Does NZM2 stock pay dividends?
NOVONESIS (NOVOZYMES) B (NZM2.DE) has a dividend yield of 1.58%. The yearly dividend amount is currently 0.67.
How is the ChartMill rating for NOVONESIS (NOVOZYMES) B?
NZM2.DE has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Is NOVONESIS (NOVOZYMES) B (NZM2.DE) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on NZM2.DE.
Can you provide the upcoming earnings date for NOVONESIS (NOVOZYMES) B?
NOVONESIS (NOVOZYMES) B (NZM2.DE) will report earnings on 2026-02-25, after the market close.